Evidence map›Paper›PMID 32407148›Full record

Trial reportDiabetes technology & therapeutics2020

DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen.

Sylvia Franc, Hélène Hanaire, Pierre-Yves Benhamou, Pauline Schaepelynck, Bogdan Catargi, Anne Farret, Pierre Fontaine, Bruno Guerci, Yves Reznik, Nathalie Jeandidier and 9 more

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Diabetes technology & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Tubeless Insulin Pump Combined with a Cloud-Based Data Management Platform: Real-World Evidence from 14,765 French People with Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  7. Review
  8. Review
  9. Digital Health Technology in Diabetes Management in the Asia-Pacific Region: A Narrative Review of the Current Scenario and Future Outlook.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sylvia FrancDepartment of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, and Centre d'étude et de Recherche pour l'Intensification du Traitement du Diabète (CERITD), Evry, France.
Hélène HanaireDepartment of Diabetology, Metabolic Diseases and Nutrition, CHU Toulouse, University of Toulouse, Toulouse, France.
Pierre-Yves BenhamouDepartment of Diabetology, Pôle DigiDune, University Hospital, Grenoble, France.
Pauline SchaepelynckDepartment of Nutrition-Endocrinology-Metabolic Disorders, Marseille University Hospital, Sainte Marguerite Hospital, Marseille, France.
Bogdan CatargiDepartment of Endocrinology and Diabetes, University Hospital, Bordeaux, France.
Anne FarretDepartment of Endocrinology, Diabetes and Nutrition, University Hospital, Montpellier, France.
Pierre FontaineDepartment of Diabetology, University Hospital, Lille, France.
Bruno GuerciEndocrinology-Diabetes Care Unit, University of Lorraine, Vandoeuvre Lès Nancy, France.
Yves ReznikDepartment of Endocrinology, University of Caen Côte de Nacre Regional Hospital Center, Caen, France.
Nathalie JeandidierDepartment of Endocrinology, Diabetes and Nutrition, CHU of Strasbourg, Strasbourg, France.
Alfred PenfornisDepartment of Diabetology, Metabolic Diseases and Nutrition, CHU Toulouse, University of Toulouse, Toulouse, France.
Sophie BorotCentre Hospitalier Universitaire Jean Minjoz, Service d'Endocrinologie-Métabolisme et Diabétologie-Nutrition, Besançon, France.
Lucy ChaillousCHU de Nantes-Hospital Laennec, Saint-Herblain, France.
Pierre SerusclatEndocrinology, Diabetology and Nutrition, Clinique Portes du Sud, Venissieux, France.
Yacine KherbachiSanofi-Diabetes, Gentilly, France.
Geneviève d'OrsayVoluntis, Suresnes, France.
Bruno DetournayCEMKA-EVAL, Bourg-la-Reine, France.
Pierre SimonNational Association of Telemedicine, Evry, France.
Guillaume CharpentierDepartment of Diabetes, Sud-Francilien Hospital, Corbeil-Essonnes, and Centre d'étude et de Recherche pour l'Intensification du Traitement du Diabète (CERITD), Evry, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2InsulinMobile ApplicationsAdultBlood GlucoseFemaleGlycated HemoglobinHumansHypoglycemic AgentsInternetMaleMiddle AgedTelemetryBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinGlycemic controlHbA1cHypoglycemiaInsulin therapyTelemedicine

Identifiers

PMID32407148
PMCPMC7757616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.